Remogliflozin A,
329045-45-6,
UNII-13ZPK7A4MJ,
13ZPK7A4MJ,
SCHEMBL2253397,
CHEMBL3958686,
DTXSID30186563,
GSINGUMRKGRYJP-VZWAGXQNSA-N,
ZINC95913226,
AKOS027325100,
GSK 189074,
beta-D-Glucopyranoside, 5-methyl-4-((4-(1-methylethoxy)phenyl)methyl)-1-(1-methylethyl)-1H-pyrazol-3-yl,
A13971,
3-(beta-D-glucopyranosyloxy)-4-[(4-iso-propoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole,
3-(beta-D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole,
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yloxy)tetrahydro-2H-pyran-3,4,5-triol,
remogliflozin,
Remogliflozin - GSK 189074,
CID9846588,
CID 9846588,
?-?D-?Glucopyranoside, 5-?methyl-?4-?[[4-?(1-?methylethoxy)?phenyl]?methyl]?-?1-?(1-?methylethyl)?-?,